» Articles » PMID: 26851140

Serial Measurements of Troponin and Echocardiography in Patients with Moderate-to-severe Acute Respiratory Distress Syndrome

Overview
Journal J Crit Care
Specialty Critical Care
Date 2016 Feb 7
PMID 26851140
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To assess the clinical significance of serial troponin I levels (measured in the first 72 hours from admission) in 42 consecutive patients with moderate-to-severe acute respiratory distress syndrome (ARDS). Echocardiography and electrocardiogram testings were serially performed in the time window.

Materials And Methods: Troponin I was measured every 12 hours in the first 72 hours from intensive care unit (ICU) admission. Echocardiography and electrocardiogram testings were serially performed in the same time window to clinically interpret Tn I levels.

Results: Patients with admission positive Tn I (38.1%) showed higher values of systolic pulmonary hypertension (P = .013) associated with significantly lower values of tricuspid annular plane excursion (P = .011). Twenty-five patients (25/42, 59.5%) exhibited positive peak Tn I and at second echocardiographic assessment exhibited significant lower tricuspid annular plane excursion values (P = .005). At stepwise regression analysis the following variables were an independent predictor for in-ICU mortality: Pco2 (OR 1.08, 95% CI 1.011-1.161, P = .023), systolic pulmonary arterial hypertension (OR 0.83, 95% CI 0.701-0.977, P = .002), log peak Tn I (OR 3.56, 95% CI 1.045-12.132, P = .042).

Conclusions: In moderate-to-severe ARDS, serial troponin I assessment together with echocardiography evaluation helped to identify a subgroup at higher risk for in-ICU death. Moreover, troponin release can be related to right ventricular dysfunction, thus highlighting the clinical role of echocardiography in ARDS patients.

Citing Articles

ARDS Clinical Practice Guideline 2021.

Tasaka S, Ohshimo S, Takeuchi M, Yasuda H, Ichikado K, Tsushima K J Intensive Care. 2022; 10(1):32.

PMID: 35799288 PMC: 9263056. DOI: 10.1186/s40560-022-00615-6.


Role of Cardiac Imaging Modalities in the Evaluation of COVID-19-Related Cardiomyopathy.

Cecchetto A, Nistri S, Baroni G, Torreggiani G, Aruta P, Pergola V Diagnostics (Basel). 2022; 12(4).

PMID: 35453944 PMC: 9025970. DOI: 10.3390/diagnostics12040896.


Characterization of Inhaled Nitric Oxide Use for Cardiac Indications in Pediatric Patients.

Yates A, Berger J, Reeder R, Banks R, Mourani P, Berg R Pediatr Crit Care Med. 2022; 23(4):245-254.

PMID: 35200229 PMC: 9058189. DOI: 10.1097/PCC.0000000000002917.


Cardiac biomarkers in acute respiratory distress syndrome: a systematic review and meta-analysis.

Jayasimhan D, Foster S, Chang C, Hancox R J Intensive Care. 2021; 9(1):36.

PMID: 33902707 PMC: 8072305. DOI: 10.1186/s40560-021-00548-6.


Combined lung and cardiac ultrasound in COVID-related acute respiratory distress syndrome.

Lazzeri C, Bonizzoli M, Batacchi S, Socci F, Matucci-Cerinic M, Peris A Intern Emerg Med. 2021; 16(7):1779-1785.

PMID: 33704675 PMC: 7947148. DOI: 10.1007/s11739-021-02646-7.